Actively Recruiting
Remimazolam and Emergence Delirium in Pediatrics
Led by Peking University First Hospital · Updated on 2025-07-01
248
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Emergence delirium is a common complication in pediatrics undergoing neurosurgery. Previous study showed that a single bolus of remimazolam was associated with lower incidence of postoperative agitation. Present study was designed to investigate if remimazolam supplemented to sevoflurane anesthesia could decrease the risk of emergence delirium in pediatrics undergoing neurosurgery.
CONDITIONS
Official Title
Remimazolam and Emergence Delirium in Pediatrics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 1 to 6 years old
- Planned to receive elective neurosurgery under general anesthesia
- Expected duration of surgery greater than 1 hour
You will not qualify if you...
- Allergy to benzodiazepines
- Use of other sedatives within 12 hours before surgery such as benzodiazepines, propofol, or chloral hydrate
- ASA classification IV or above
- Unable to complete emergence delirium assessment due to language, hearing, or vision impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
Not Yet Recruiting
2
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
Research Team
D
Dong-liang Mu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here